Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando J De Miguel

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cancer Research|December 28, 2013
Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancerFernando J de Miguel, Ravi D Sharma, María J Pajares, et al.
BMC Genomics|June 19, 2016
EventPointer: an effective identification of alternative splicing events using junction arraysJuan P Romero, Ander Muniategui, Fernando J De Miguel, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Overexpressed <i>Malat1</i> Drives Metastasis through Inflammatory Reprogramming of Lung Adenocarcinoma MicroenvironmentElena Mart Nez-Terroba, Fernando J de Miguel, Vincent Li, et al.
Science Immunology|June 14, 2024
Overexpression of <i>Malat1</i> drives metastasis through inflammatory reprogramming of the tumor microenvironmentElena Martinez-Terroba, Leah M Plasek-Hegde, Ioannis Chiotakakos, et al.
BMC Genomics|September 27, 2018
Comparison of RNA-seq and microarray platforms for splice event detection using a cross-platform algorithmJuan P Romero, María Ortiz-Estévez, Ander Muniategui, et al.
Molecular Oncology|August 25, 2016
A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancerFernando J de Miguel, María J Pajares, Elena Martínez-Terroba, et al.
Nature Communications|December 4, 2021
Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor proteinBrajendra K Tripathi, Meghan F Anderman, Disha Bhargava, et al.
Journal of Virology|July 19, 2019
Antiangiogenic Vascular Endothelial Growth Factor-Blocking Peptides Displayed on the Capsid of an Infectious Oncolytic Parvovirus: Assembly and Immune InteractionsEsther Grueso, Cristina Sánchez-Martínez, Tania Calvo-López, et al.
Journal for Immunotherapy of Cancer|July 12, 2019
Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumorsDeborah Ayeni, Braden Miller, Alexandra Kuhlmann, et al.
American Journal of Respiratory and Critical Care Medicine|January 13, 2018
Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated EffectsDaniel Ajona, Carolina Zandueta, Leticia Corrales, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cancer Research|December 28, 2013
Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancerFernando J de Miguel, Ravi D Sharma, María J Pajares, et al.
BMC Genomics|June 19, 2016
EventPointer: an effective identification of alternative splicing events using junction arraysJuan P Romero, Ander Muniategui, Fernando J De Miguel, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Overexpressed <i>Malat1</i> Drives Metastasis through Inflammatory Reprogramming of Lung Adenocarcinoma MicroenvironmentElena Mart Nez-Terroba, Fernando J de Miguel, Vincent Li, et al.
Science Immunology|June 14, 2024
Overexpression of <i>Malat1</i> drives metastasis through inflammatory reprogramming of the tumor microenvironmentElena Martinez-Terroba, Leah M Plasek-Hegde, Ioannis Chiotakakos, et al.
BMC Genomics|September 27, 2018
Comparison of RNA-seq and microarray platforms for splice event detection using a cross-platform algorithmJuan P Romero, María Ortiz-Estévez, Ander Muniategui, et al.
Molecular Oncology|August 25, 2016
A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancerFernando J de Miguel, María J Pajares, Elena Martínez-Terroba, et al.
Nature Communications|December 4, 2021
Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor proteinBrajendra K Tripathi, Meghan F Anderman, Disha Bhargava, et al.
Journal of Virology|July 19, 2019
Antiangiogenic Vascular Endothelial Growth Factor-Blocking Peptides Displayed on the Capsid of an Infectious Oncolytic Parvovirus: Assembly and Immune InteractionsEsther Grueso, Cristina Sánchez-Martínez, Tania Calvo-López, et al.
Journal for Immunotherapy of Cancer|July 12, 2019
Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumorsDeborah Ayeni, Braden Miller, Alexandra Kuhlmann, et al.
American Journal of Respiratory and Critical Care Medicine|January 13, 2018
Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated EffectsDaniel Ajona, Carolina Zandueta, Leticia Corrales, et al.
Pageof 2